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Abstract
Biofilms formed by fungal organisms are associated with drastically enhanced resistance against most antimicrobial
agents, contributing to the persistence of the fungi despite antifungal therapy. The purpose of this study is to
combine the unique properties of nanoparticles with the antimicrobial activity of the Rosmarinus officinalis essential
oil in order to obtain a nanobiosystem that could be pelliculised on the surface of catheter pieces, in order to
obtain an improved resistance to microbial colonization and biofilm development by Candida albicans and C.
tropicalis clinical strains. The R. officinalis essential oils were extracted in a Neo-Clevenger type apparatus, and its
chemical composition was settled by GC-MS analysis. Functionalized magnetite nanoparticles of up to 20 nm size
had been synthesized by precipitation method adapted for microwave conditions, with oleic acid as surfactant. The
catheter pieces were coated with suspended core/shell nanoparticles (Fe3O4/oleic acid:CHCl3), by applying a
magnetic field on nanofluid, while the CHCl3 diluted essential oil was applied by adsorption in a secondary
covering treatment. The fungal adherence ability was investigated in six multiwell plates, in which there have been
placed catheters pieces with and without hybrid nanoparticles/essential oil nanobiosystem pellicle, by using
culture-based methods and confocal laser scanning microscopy (CLSM). The R. officinalis essential oil coated
nanoparticles strongly inhibited the adherence ability and biofilm development of the C. albicans and C. tropicalis
tested strains to the catheter surface, as shown by viable cell counts and CLSM examination. Due to the important
implications of Candida spp. in human pathogenesis, especially in prosthetic devices related infections and the
emergence of antifungal tolerance/resistance, using the new core/shell/coated shell based on essential oil of R.
officinalis to inhibit the fungal adherence could be of a great interest for the biomedical field, opening new
directions for the design of film-coated surfaces with antibiofilm properties.
Background
The increasing occurrence of multidrug resistant, exten-
sive drug resistant and pandrug resistant microbial
strains has gradually rendered traditional antimicrobial
treatment ineffective [1]. The prognosis is worsened by
the formation of microbial biofilms on the biomaterials
used in medicine due to their phenotypic resistance,
even if the component cells tested in suspension (by the
standard method) are susceptible to some antibiotics.
Recent public announcements stated that 60% to 85% of
all microbial infections involve biofilms developed on
natural, intact or damaged tissues (skin, mucosa,
endothelial epithelia and teeth), or artificial devices (cen-
tral venous catheters, peritoneal, urinary catheters, den-
tal materials, cardiac valves, intrauterine contraceptive
devices, contact lenses and other implants). The inser-
tion of the prosthetic medical devices for different
exploratory or therapeutical purposes, especially in
severe pathological conditions, represents a risk factor
for the occurrence of chronic infections in developed
countries, being characterized by slow onset, middle
intensity symptoms, chronic evolution, and resistance to
antibiotic treatment [2]. In this context, finding and
testing new preventive/therapeutic strategies for
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top priority at the international level. Two main strate-
gies have been employed for the prevention of catheter
associated infections: a) development of biomaterials
with antiadhesive properties using physico-chemical
methods [3-5] and b) incorporation or coating biomater-
ials which significantly reduce the microbial adherence,
e.g., in vitro urinary catheters impregnated with silver
ions. However, recent research is raising the risk of
selecting resistance by coating catheters with antimicro-
bial substances [6]. Nanotechnology is expected to open
some new ways to fight and prevent diseases using
atomic scale tailoring of materials [7]. There are a lot of
reports on the antimicrobial and antibiofilm properties
of different types of nanoparticles, especially heavy
metal containing ones (silver, copper, gold and ZnO)
( [ 8 - 1 0 ] ,a sw e l la st h ec o r e / s h e l ln a n o s y s t e m s( e . g . ,
CoFe2O4/oleic acid, Fe3O4/oleic acid and Fe3O4/
PEG600) [11,12]. Although the potential of natural com-
pounds of vegetal origin to be used as therapeutical
remedies is known since longtime, their use is still
empirical, but the problem of microbial resistance as
well as the negative impact of the chemical substances
discharged in the external environment on the ecologi-
cal balance has reinforced the studies concerning the
characterization of the chemical structures of vegetal
products and the active doses, aiming to understand
their specific mechanisms of action. The efficiency of
essential oils obtained from different plant species and
their synergic effects as alternative strategies for the
treatment of severe infections caused by highly resistant
bacteria was already proved [13,14]. The purpose of this
study is to combine the unique properties of nanoparti-
cles with the antimicrobial activity of the Rosmarinus
officinalis essential oil in order to obtain a nanobiosys-
tem that could be pelliculised on the surface of catheter
pieces, in order to obtain an improved resistance to
microbial colonization and biofilm development.
Methods
Extraction and analysis of R. officinalis essential oils
The essential oil microwave assisted extraction was per-
formed in a Neo-Clevenger type apparatus, and its che-
mical composition was settled by GC-MS analysis. Gas
chromatographic analysis was performed using an Agi-
lent 6890 Series GC System gas chromatograph (Agilent
Technologies Inc., Santa Clara, CA, USA) fitted with a
splitless injector for a low background with an injector
liner split/splitless under a column head pressure of
12.5 psi and H2 as carrier gas at a flow rate of 1.2 ml/
min. Oven temperature was programmed from 50 to
300°Cat 5°C/min. Injector and detector temperatures
were 250°C. A capillary column DB5-MS fused-silica
J&W Scientific Inc. (Krackeler Scientific, Inc., Albany,
NY) (30 m × 0.25 mm i.d.; 0.25 μmf i l m )w a su s e d .
Detection was carried out with a 5973 mass-selective
single quadrupole detector (Agilent technologies).
Operation control and the data process were carried out
by Agilent Technologies ChemStation software. The
mass spectrometer was calibrated before use with per-
fluorotributylamine as a calibration standard.
Synthesis and characterization of hybrid nanomaterial
core/shell/coated shell
Functionalized magnetite nanoparticles had been synthe-
sized by precipitation method adapted for microwave
conditions, with oleic acid as surfactant. High resolution
transmission electron microscopy was used as a primary
characterization method for Fe3O4/oleic acid- core/shell
nanostructure with dimensions not exceeding 20 nm,
according to our previous studies [15,16]. The nanobio-
system was obtained by coating the prosthetic device
with suspended core/shell nanoparticles (Fe3O4/oleic
acid:CHCl3 0.33% (w/v)). The layer of core/shell nanos-
tructure on prosthetic device was achieved by submer-
ging the catheter pieces in 5 ml of the nanofluid
represented by Fe3O4/oleic acid:CHCl3 0,33% (w/v).
The nanoparticles were aligned in a magnetic field of
100 Kgf applied for 1 s, and thereafter, the catheter
pieces have been extemporaneously dried at room tem-
perature. The rapid drying was facilitated by the conve-
nient volatility of chloroform. In order to achieve core/
shell/coated-shell type samples, the extra-shell (CHCl3
diluted essential oil, 160 μL/mL) was applied by adsorp-
tion in a secondary covering treatment, performed by
submerging again for 1 s the catheter samples previously
coated with Fe 3O4/oleic acid in 5 ml of CHCl3 diluted
essential oil, followed by extemporaneous drying at
room temperature (Figure 1). The coated prosthetic
devices were then sterilized by ultraviolet irradiation for
15 min.
Fungal model
The artificial monospecific biofilms were developed
using two strains of C. tropicalis and C. albicans
recently isolated from clinical specimens and identified
by using Vitek II (bioMérieux, Inc., Durham, NC auto-
matic system and previously tested for their susceptibil-
ity to currently used antifungals (voriconazole,
itraconazole, caspofungin, amphotericin B, fluconazole
and flucytosin) and to some essential oils [13,14,17].
Microbial adherence to the inert and modified prosthetic
devices
The microbial adherence ability was investigated in six
multiwell plates, in which there have been placed cathe-
ters pieces of 1 cm with and without nanobiosystem.
Plastic wells were filled with liquid medium, inoculated
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incubated for 72 h at 30°C. After 24 h, the culture med-
ium was removed, the catheters were washed three
times in phosphate buffered saline (PBS) in order to
remove the non-adherent strains, and fresh Glucose
broth was added. Also viable cell counts (VCCs) have
been achieved for both working variants (coated and
uncoated catheter pieces) at each 24 h in order to assess
the biofilm forming ability of the two strains. The
adhered cells have been removed from the catheter sec-
tions by vortexing and brief sonication and serial dilu-
tions ranging from 10
-1 to 10
-of the obtained inocula
have been spotted on Sabouraud agar, incubated for 24
h at 30°C and assessed for VCCs [18].
Direct examination of biofilm architecture by CLSM
In order to evaluate the biofilm formation on coated
and uncoated catheters, a confocal laser scanning micro-
scopy (CLSM) was used. After 48 and 72 h of incuba-
tion, the samples were removed from the plastic wells,
washed three times with PBS, fixed with cold methanol,
and dried before microscopic examination. Samples
were visualized in reflection and transmission mode by
using a Leica microscope (TCS-SP CSLM model),
equipped with PL FLUOTAR (40X NA0.7, electronic
zoom 1), and an He-Ne laser tuned on 633 nm wave-
length. A lateral resolution of about 600 nm was
achieved [19]. The Leica software was used for examin-
ing the surface topography.
Results and discussions
The increasing resistance of C. albicans towards the
existent antifungal compounds and the reduced number
of available drugs led to the search of new therapeutic
alternatives among plants and their essential oils,
empirically used due to their antifungal proprieties.
Plant oils traditionally used for domestic and therapeutic
purposes are increasingly claimed to have broad spec-
trum antimicrobial properties. Some essential oils have
been suggested to have potent antimicrobial activity,
including antihelmintic, skin infections and insect bites,
chicken pox, colds, flu and measles sinus congestion,
asthma, bronchitis, pneumonia, tuberculosis, and cholera
properties, due to their phenolic, alcoholic, and
Legend:  Essential oil  Core/shell  Catheter section 
Figure 1 Core/shell/coated-shell nanobiosystem (transversal section).
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the inhibitory effect of 30 plant oils against one biofilm
forming C. albicans strain isolated from a clinical sam-
ple, out of which eucalyptus, peppermint, ginger grass,
and clove oils proved to be fungistatic, fungicidal, and
antibiofilm agents [20].
Previous studies indicated the antimicrobial activity of
essential-oil rich fractions of R. officinalis against gram-
positive (Staphylococcus aureus and Bacillus subtilis),
gram-negative bacterial strains (Escherichia coli and
Pseudomonas aeruginosa) but also against yeasts (C.
albicans)a n dm o l d s( Aspergillus niger), the main com-
ponents found in the oil (80%) being represented by
alpha-Pinene, 1,8-cineole, camphor, verbenone, and bor-
neol [21].
The identified phytocomponents from R. officinalis
essential oil analyzed in our study are listed in Table 1.
The principal components percentage was 40.596%
Eucalyptol, 11.389% Camphor, 10.19% Caryophyllene,
and alpha-Pinene 18.42% from the total area.
The microbial biofilm is defined as a sessile microbial
community composed of cells irreversibly attached to a
substratum and between them, embedded in a matrix of
extracellular polymeric substances produced by them-
selves and which presents a modified phenotype with
respect to their rate of growth as well as gene transcrip-
tion [22]. The biofilm cells are resistant to all kinds of
antimicrobial substances: antibiotics, antiseptics, disin-
fectants; this type of resistance, consecutive to biofilm
formation is phenotypical, behavioral, and more
recently, called tolerance [23]. Tolerance is defined as
the ability to survive from bactericidal factors without
necessarily expressing a genetic resistance mechanism.
The microbial species of clinical interest, often involved
in biofilm associated diseases, are belonging to a very
large spectrum, from the gram positive (Staphylococcus
epidermidis and Staphylococcus aureus)t ot h eg r a m
negative pathogens (Pseudomonas aeruginosa,and
Escherichia coli) and to different members of the Can-
dida genus. Biofilms formed by fungal organisms are
associated with drastically enhanced resistance against
most antimicrobial agents, contributing to the persis-
tence of the fungi despite antifungal therapy [20,24].
Although C. albicans is the predominant etiologic
agent of candidiasis, other Candida species that tend to
be less susceptible to the commonly used antifungal
drugs such as C. krusei, C. glabrata, C. lusitaniae,a n d
the newest Candida species, C dubliniensis,h a v e
emerged as substantial opportunistic pathogens [25].
The outlined work investigates the potential of R. offici-
nalis essential oil stabilized in nanolayer and its effect
on biofilm formation of C. albicans and C. tropicalis
strains, previously isolated from clinical samples. Confo-
cal laser scanning microscopy (CLSM) was used for the
analysis of fungal biofilms developed on the uncoated
catheters and on the catheters pelliculised with the plant
oils included in the nanosystem. Visualization of control
biofilms revealed the ability of the tested strains to form
biofilms on the glass coverlisps. The visualization of fun-
gal biofilms developed at 48 h revealed the presence of
yeast-phase cells attached to the inert substratum and
the microcolony yeast basal layer formation, as well as
the expansion of the biofilm architecture by the occur-
rence of hyphal and pseudohyphal forms, that dimin-
ished at 72 h (Figure 2). Visualization of the biofilm
structure in the presence of the tested hybrid nanosys-
tem revealed an important reduction in adhering cells
and biofilm development as compared to the untreated
biofilm, the adhered yeast-cells being practically absent
at 48 and 72 h for both tested strains (Figure 2). This
suggests that despite the relative minimal diffusion due
to the inclusion of the essential oil in the nanoparticles
layer, the vegetal compounds may be exerting a meta-
bolic interference in biofilm.
The antibiofilm effect of the tested nanobiosystem
was also proved by the significant reduction of viable
cell number in the presence of the protective pellicle
of the hybrid nanobiosystem. In the case of C. albicans
biofilms, although a slight reduction was observed in
the early phase of biofilm development (at 24 h), a
clear inhibitory effect was observed in the case of 48-
and 72-h biofilms, the VCCs drastically dropping with
approximately 85% to 98%, as compared to the
uncoated controls (Figure 3). Comparatively, in case of
C. tropicalis biofilm, the most intensive decrease of
viable cells adhered to the catheter sections was
observed at 24 h (Figure 3). These results could be
probably related to the earlier production of
Table 1 Chemical composition of R.officinalis L. essential
oils
Peak Compound RT Relative content (%)
1 Tricyclene 4.557 0.527
2 Alpha-pinene 4.96 18.42
3 Camphene 5.274 3.532
4 Beta-pinene 6.08 8.162
5 Alpha-phellandrene 6.852 0.164
6 Eucalyptol 7.793 40.596
7 Alpha-terpinene 8.509 0.49
8 Camphor 11.073 11.389
9 Borneol 11.621 0.286
10 Alpha-terpineol 12.394 0.327
11 Bornyl acetate 15.136 2.602
12 Copaene 17.487 0.201
13 Caryophyllene 18.685 10.19
14 Caryophyllene oxide 22.615 0.873
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as compared with C. albicans (72 h). These structures
could represent additional contact and adherence
points to inert or cellular substrata and also sources of
genetic variability and adaptation to different limitative
conditions, being responsible, for example, for the high
tolerance to antifungal substances [26].
Conclusions
The R. officinalis essential oil coated nanoparticles
strongly inhibited the adherence ability and biofilm
development on catheter surface of the C.albicans and
C. tropicalis tested strains, as shown by VCCs and
CLSM examination. Due to the important implications
of Candida spp. in human pathogenesis, especially in
A.
B.
C.  
D.
E.
F.
G.
H.
Figure 2 CLSM images.( A) adherent C. albicans strain at 48 h; (B) the absence of adherent yeast -cells and C. albicans biofilm development in
the presence of hybrid nanobiosystem at 72 h; (C) adherent C. albicans strain at 72 h; (D) the absence of adherent yeast-cells and C. albicans
biofilm development in the presence of hybrid nanobiosystem at 72 h; (E) adherent C. tropicalis strain at 48 h; (F) the rare presence of adherent
yeast-cells and C. tropicalis biofilm development in the presence of hybrid nanobiosystem at 72 h; (G) adherent C. tropicalis strain at 72 h; and
(H) the rare presence of adherent yeast-cells and C. tropicalis biofilm development in the presence of hybrid nanobiosystem at 72 h.
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ance/resistance, using the new core/shell/coated shell
based on essential oil of R. officinalis to inhibit fungal
adherence to prosthetic device could be of a great inter-
est for the biomedical field. These materials-based
approaches to control of fungal adherence could provide
both (i) new tools to study mechanisms of fungal viru-
lence and biofilm formation, and (ii) approaches to the
design of film-coated surfaces or to treat the surfaces of
solid and fiber-based materials that prevent or disrupt
the formation of fungal biofilms.
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